Decellularized tissue-engineered blood vessel as an arterial conduit

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 22, 2011, Pages 9214-9219

  Quint, Clay ^a   Kondo, Yuka ^b   Manson, Roberto J ^c   Lawson, Jeffrey H ^c   Dardik, Alan ^b   Niklason, Laura E ^a,b  

^a Yale University   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bypass graft; Collagen; Mechanical conditioning

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

ANIMAL CELL; ARTERY BYPASS; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOMIMETICS; BLOOD VESSEL; CAROTID ARTERY; CONTROLLED STUDY; END TO SIDE ANASTOMOSIS; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GRAFT OCCLUSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VEIN GRAFT;

ANIMALS; ARTERIES; BLOOD COAGULATION; BLOOD VESSEL PROSTHESIS; CAROTID ARTERIES; CELL PROLIFERATION; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; PERFUSION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; SIROLIMUS; STEM CELLS; SWINE; TISSUE ENGINEERING;

MAMMALIA; SUS; TOBACCO ETCH VIRUS;

EID: 79959348117     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1019506108     Document Type: Article

References (39)

1. Yeager RA, et al. (1982) Differential patency and limb salvage for polytetrafluoroethylene and autogenous saphenous vein in severe lower extremity ischemia. Surgery 91:99-103. (Pubitemid 12212558)
2. Veith FJ, Moss CM, Sprayregen S, Montefusco C (1979) Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity. Surgery 85:253-256. (Pubitemid 10206836)
3. Giannoukas AD, et al. (1997) Pre-bypass quality assessment of the long saphenous vein wall with ultrasound and histology. Eur J Vasc Endovasc Surg 14:37-40. (Pubitemid 27380179)
4. Weinberg CB, Bell E (1986) A blood vessel model constructed from collagen and cultured vascular cells. Science 231:397-400. (Pubitemid 16108649)
5. Kakisis JD, Liapis CD, Breuer C, Sumpio BE (2005) Artificial blood vessel: The Holy Grail of peripheral vascular surgery. J Vasc Surg 41:349-354. (Pubitemid 40342491)
6. Schmidt CE, Baier JM (2000) Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 21:2215-2231.
7. Amiel GE, et al. (2006) Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng 12:2355-2365. (Pubitemid 44734993)
8. Kaushal S, et al. (2001) Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7:1035-1040. (Pubitemid 32937384)
9. Cho SW, et al. (2005) Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 241:506-515.
10. Asahara T, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967. (Pubitemid 27087709)
11. Mead LE, Prater D, Yoder MC, Ingram DA (2008) Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol, Chapter 2, Unit 2C 1.
12. Kalka C, et al. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427. (Pubitemid 30183318)
13. Dahl SL, Koh J, Prabhakar V, Niklason LE (2003) Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 12:659-666. (Pubitemid 37204423)
14. McAllister TN, et al. (2009) Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: A multicentre cohort study. Lancet 373:1440-1446.
15. Niklason LE, et al. (1999) Functional arteries grown in vitro. Science 284:489-493. (Pubitemid 29289622)
16. Niklason LE, et al. (2001) Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg 33:628-638. (Pubitemid 32215616)
17. L'Heureux N, Pâquet S, Labbé R, Germain L, Auger FA (1998) A completely biological tissue-engineered human blood vessel. FASEB J 12:47-56. (Pubitemid 28060270)
18. Topper JN, Cai J, Falb D, Gimbrone MA, Jr. (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: Cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93:10417-10422.
19. Brown MA, Wallace CS, Angelos M, Truskey GA (2009) Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress. Tissue Eng Part A 15:3575-3587.
20. Case J, et al. (2007) Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35: 1109-1118. (Pubitemid 46921310)
21. Timmermans F, et al. (2009) Endothelial progenitor cells: Identity defined? J Cell Mol Med 13:87-102.
22. Braun-Dullaeus RC, et al. (2001) Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol 21:1152-1158. (Pubitemid 34215143)
23. Morice MC, et al.; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346: 1773-1780.
24. Stabile E, et al. (2003) Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ Res 93:1059-1065. (Pubitemid 37485036)
25. Tsutsumi H, Miyawaki F, Arakawa H, Tsuji T, Tanigawa M (2001) Experience of vein grafting in Göttingen minipigs. Exp Anim 50:191-195. (Pubitemid 33620390)
26. Stroncek JD, et al. (2009) Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. Tissue Eng Part A 15:3473-3486.
27. Kibbe MR, et al. (2001) Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg 34: 156-165. (Pubitemid 33660705)
28. Ahanchi SS, Tsihlis ND, Kibbe MR (2007) The role of nitric oxide in the pathophysiology of intimal hyperplasia. J Vasc Surg 45(Suppl A):A64-A73.
29. Davis C, Fischer J, Ley K, Sarembock IJ (2003) The role of inflammation in vascular injury and repair. J Thromb Haemost 1:1699-1709.
30. Owens CD (2010) Adaptive changes in autogenous vein grafts for arterial reconstruction: Clinical implications. J Vasc Surg 51:736-746.
31. Shimizu K, et al. (2001) Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 7:738-741. (Pubitemid 32588032)
32. Diao Y, et al. (2008) Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. Am J Pathol 172:839-848. (Pubitemid 351354555)
33. Martin KA, et al. (2004) The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol 286:C507-C517. (Pubitemid 38292656)
34. Wang Y, et al. (2007) Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Circ Res 101:560-569. (Pubitemid 351325873)
35. Sousa JE, et al. (2005) Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 111:2326-2329. (Pubitemid 40647068)
36. Dahl SL, et al. (2011) Readily available tissue-engineered vascular grafts. Sci Transl Med 3:68ra9.
37. Gui L, Chan SA, Breuer CK, Niklason LE (2010) Novel utilization of serum in tissue decellularization. Tissue Eng Part C Methods 16:173-184.
38. Zheng L, Ben LH, Pober JS, Bothwell AL (2002) Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2. J Immunol 169:6850-6855. (Pubitemid 36899270)
39. Gong Z, Niklason LE (2008) Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22:1635-1648. (Pubitemid 351811442)